These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Strafella AP, Ko JH, Monchi O. Neuroimage; 2006 Jul 15; 31(4):1666-72. PubMed ID: 16545582 [Abstract] [Full Text] [Related]
6. Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET study. Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O. Eur J Neurosci; 2005 Dec 15; 22(11):2946-52. PubMed ID: 16324129 [Abstract] [Full Text] [Related]
8. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET. Tedroff J, Pedersen M, Aquilonius SM, Hartvig P, Jacobsson G, Långström B. Neurology; 1996 May 15; 46(5):1430-6. PubMed ID: 8628494 [Abstract] [Full Text] [Related]
9. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Frank GK, Bailer UF, Henry SE, Drevets W, Meltzer CC, Price JC, Mathis CA, Wagner A, Hoge J, Ziolko S, Barbarich-Marsteller N, Weissfeld L, Kaye WH. Biol Psychiatry; 2005 Dec 01; 58(11):908-12. PubMed ID: 15992780 [Abstract] [Full Text] [Related]
14. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Drevets WC, Price JC, Kupfer DJ, Kinahan PE, Lopresti B, Holt D, Mathis C. Neuropsychopharmacology; 1999 Dec 06; 21(6):694-709. PubMed ID: 10633475 [Abstract] [Full Text] [Related]
15. Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine. Oswald LM, Wong DF, McCaul M, Zhou Y, Kuwabara H, Choi L, Brasic J, Wand GS. Neuropsychopharmacology; 2005 Apr 06; 30(4):821-32. PubMed ID: 15702139 [Abstract] [Full Text] [Related]
16. NMDA antagonist effects on striatal dopamine release: positron emission tomography studies in humans. Kegeles LS, Martinez D, Kochan LD, Hwang DR, Huang Y, Mawlawi O, Suckow RF, Van Heertum RL, Laruelle M. Synapse; 2002 Jan 06; 43(1):19-29. PubMed ID: 11746730 [Abstract] [Full Text] [Related]
17. Effect of simple motor performance on regional dopamine release in the striatum in Parkinson disease patients and healthy subjects: a positron emission tomography study. Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Sakamoto M. J Cereb Blood Flow Metab; 2002 Jun 06; 22(6):746-52. PubMed ID: 12045673 [Abstract] [Full Text] [Related]
18. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, McCracken JT. Arch Gen Psychiatry; 2006 Jul 06; 63(7):808-16. PubMed ID: 16818870 [Abstract] [Full Text] [Related]
19. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Drevets WC, Gautier C, Price JC, Kupfer DJ, Kinahan PE, Grace AA, Price JL, Mathis CA. Biol Psychiatry; 2001 Jan 15; 49(2):81-96. PubMed ID: 11164755 [Abstract] [Full Text] [Related]
20. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, Huang Y, Simpson N, Ngo K, Van Heertum R, Laruelle M. J Cereb Blood Flow Metab; 2001 Sep 15; 21(9):1034-57. PubMed ID: 11524609 [Abstract] [Full Text] [Related] Page: [Next] [New Search]